Anti-NMDA receptor encephalitis: Difference between revisions
No edit summary |
CSV import |
||
| Line 1: | Line 1: | ||
{{SI}}<br> | |||
{{Infobox medical condition | |||
| name = Anti-NMDA receptor encephalitis | |||
| image = [[File:NR1-NR2B_subunit.png|250px]] | |||
| caption = Structure of the NMDA receptor, which is targeted in this condition | |||
| field = [[Neurology]], [[Psychiatry]] | |||
| symptoms = [[Psychosis]], [[Seizures]], [[Memory loss]], [[Autonomic dysfunction]], [[Movement disorders]] | |||
| onset = Typically young adults, more common in females | |||
| duration = Weeks to months | |||
| causes = Autoimmune reaction against [[NMDA receptor]]s | |||
| risks = [[Ovarian teratoma]], other tumors, [[viral infections]] | |||
| diagnosis = [[Cerebrospinal fluid]] analysis, [[EEG]], [[MRI]], detection of anti-NMDA receptor antibodies | |||
| differential = [[Infectious encephalitis]], [[Other autoimmune encephalitis]], [[Psychiatric disorders]] | |||
| treatment = [[Immunotherapy]], [[Corticosteroids]], [[Plasmapheresis]], [[Intravenous immunoglobulin]], [[Tumor removal]] | |||
| prognosis = Generally good with treatment, but can be severe or fatal if untreated | |||
| frequency = Rare | |||
}} | |||
Anti-NMDA receptor encephalitis is an autoimmune neurological disorder characterized by inflammation of the brain (encephalitis) that results from the production of antibodies against NMDA (N-methyl-D-aspartate) receptors, which are critical for memory function and cognition. | Anti-NMDA receptor encephalitis is an autoimmune neurological disorder characterized by inflammation of the brain (encephalitis) that results from the production of antibodies against NMDA (N-methyl-D-aspartate) receptors, which are critical for memory function and cognition. | ||
[[File:Extreme delta brush in anti-NMDAr encephalitis.png|thumb|Extreme delta brush in anti-NMDAr encephalitis|left]] | |||
[[File:Extreme delta brush in anti-NMDAr encephalitis.png|thumb|Extreme delta brush in anti-NMDAr encephalitis]] | |||
== Pathophysiology == | == Pathophysiology == | ||
The disease process involves the generation of autoantibodies that target NMDA receptors in the brain. These antibodies disrupt normal neurological processes by altering the functioning of these receptors, leading to the array of neurological and psychiatric symptoms seen in the condition. | The disease process involves the generation of autoantibodies that target NMDA receptors in the brain. These antibodies disrupt normal neurological processes by altering the functioning of these receptors, leading to the array of neurological and psychiatric symptoms seen in the condition. | ||
== Clinical Presentation == | == Clinical Presentation == | ||
The onset of Anti-NMDA receptor encephalitis is usually subtle, beginning with non-specific symptoms such as fever, headache, and fatigue. As the disease progresses, patients often exhibit psychiatric symptoms, which may include delusions, hallucinations, and agitation. Cognitive impairment and confusion are also common. | The onset of Anti-NMDA receptor encephalitis is usually subtle, beginning with non-specific symptoms such as fever, headache, and fatigue. As the disease progresses, patients often exhibit psychiatric symptoms, which may include delusions, hallucinations, and agitation. Cognitive impairment and confusion are also common. | ||
Over time, the disease may lead to severe neurological issues such as seizures. Autonomic instability can also occur, leading to fluctuations in heart rate, blood pressure, and respiratory rate. This disorder may progress rapidly and may lead to respiratory failure, requiring mechanical ventilation in severe cases. | Over time, the disease may lead to severe neurological issues such as seizures. Autonomic instability can also occur, leading to fluctuations in heart rate, blood pressure, and respiratory rate. This disorder may progress rapidly and may lead to respiratory failure, requiring mechanical ventilation in severe cases. | ||
== Diagnosis and Treatment == | == Diagnosis and Treatment == | ||
Diagnosis involves the detection of anti-NMDA receptor antibodies in the cerebrospinal fluid (CSF). Brain imaging and electroencephalography (EEG) may also be utilized to exclude other potential causes of encephalitis. | Diagnosis involves the detection of anti-NMDA receptor antibodies in the cerebrospinal fluid (CSF). Brain imaging and electroencephalography (EEG) may also be utilized to exclude other potential causes of encephalitis. | ||
Treatment involves the removal of antibodies, often through immunosuppressive therapies, plasmapheresis, or intravenous immunoglobulin (IVIG). Early detection and treatment of the condition can significantly improve prognosis. | Treatment involves the removal of antibodies, often through immunosuppressive therapies, plasmapheresis, or intravenous immunoglobulin (IVIG). Early detection and treatment of the condition can significantly improve prognosis. | ||
== References == | == References == | ||
<references /> | <references /> | ||
== See Also == | == See Also == | ||
* [[NMDA receptor]] | * [[NMDA receptor]] | ||
* [[Encephalitis]] | * [[Encephalitis]] | ||
Latest revision as of 13:45, 4 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Anti-NMDA receptor encephalitis | |
|---|---|
| |
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Psychosis, Seizures, Memory loss, Autonomic dysfunction, Movement disorders |
| Complications | N/A |
| Onset | Typically young adults, more common in females |
| Duration | Weeks to months |
| Types | N/A |
| Causes | Autoimmune reaction against NMDA receptors |
| Risks | Ovarian teratoma, other tumors, viral infections |
| Diagnosis | Cerebrospinal fluid analysis, EEG, MRI, detection of anti-NMDA receptor antibodies |
| Differential diagnosis | Infectious encephalitis, Other autoimmune encephalitis, Psychiatric disorders |
| Prevention | N/A |
| Treatment | Immunotherapy, Corticosteroids, Plasmapheresis, Intravenous immunoglobulin, Tumor removal |
| Medication | N/A |
| Prognosis | Generally good with treatment, but can be severe or fatal if untreated |
| Frequency | Rare |
| Deaths | N/A |
Anti-NMDA receptor encephalitis is an autoimmune neurological disorder characterized by inflammation of the brain (encephalitis) that results from the production of antibodies against NMDA (N-methyl-D-aspartate) receptors, which are critical for memory function and cognition.
Pathophysiology[edit]
The disease process involves the generation of autoantibodies that target NMDA receptors in the brain. These antibodies disrupt normal neurological processes by altering the functioning of these receptors, leading to the array of neurological and psychiatric symptoms seen in the condition.
Clinical Presentation[edit]
The onset of Anti-NMDA receptor encephalitis is usually subtle, beginning with non-specific symptoms such as fever, headache, and fatigue. As the disease progresses, patients often exhibit psychiatric symptoms, which may include delusions, hallucinations, and agitation. Cognitive impairment and confusion are also common. Over time, the disease may lead to severe neurological issues such as seizures. Autonomic instability can also occur, leading to fluctuations in heart rate, blood pressure, and respiratory rate. This disorder may progress rapidly and may lead to respiratory failure, requiring mechanical ventilation in severe cases.
Diagnosis and Treatment[edit]
Diagnosis involves the detection of anti-NMDA receptor antibodies in the cerebrospinal fluid (CSF). Brain imaging and electroencephalography (EEG) may also be utilized to exclude other potential causes of encephalitis. Treatment involves the removal of antibodies, often through immunosuppressive therapies, plasmapheresis, or intravenous immunoglobulin (IVIG). Early detection and treatment of the condition can significantly improve prognosis.
References[edit]
<references />
